Seize new opportunities for the development of metropolitan areas to make established enterprises glow with new vitality
Release time:
2020-08-14
Seizes New Opportunities for Metropolitan Area Development Brings New Vitality to Old Enterprises
Zhejiang News Client Reporter Qian Key
Zhejiang Jianfeng Group Co., Ltd. is an old enterprise in Jinhua. It has a history of 59 years since the first generation of peak people founded Jinhua Cement Factory in 1958 . From the initial small cement plant to the current cement, medicine, health products, warehousing and logistics as a supplement, cross-industry, cross-regional comprehensive enterprise group, the peak has embarked on its own development path.
In the past two years, affected by the downward pressure of the economy, some companies have been in trouble, but the spikes have bucked the trend, and good news has spread frequently. In the past five years, the average annual profit of the peak has exceeded 2.5 .8 billion yuan, and the total profit and tax paid has been 8.27 billion yuan. In the past 2016 , operating income 23.79 .4 billion and net profit 2.85 .6 billion, creating the best results in peak history. In the first quarter report of 2017 , net profit 1.12 billion yuan, once again setting a new quarterly performance record.
Under the background of "walking in the forefront and jointly building Jinhua", this year, the Jinhua Municipal Party Committee and the Municipal Government have proposed to vigorously promote the comprehensive transportation corridor, Jinyi Kechuang Corridor, and Zhejiang Central Ecological Corridor. The "Three Corridor Construction" strategic deployment has drawn a new blueprint for Jinhua's future economic and social development. In the face of new opportunities, Jiang Xiaomeng, chairman of Jianfeng Group, said that as the fourth largest metropolitan area in the province, the construction of Jinhua's "three corridors" will certainly have a positive and far-reaching impact on the trend of related industries and the positioning of enterprises in central Zhejiang. The majority of business operators and businessmen should actively participate in the new wave of reform and development, and seriously think about how to combine the construction needs of the "three corridors", give play to play to the enterprise itself, so as to catch the "big car" of Jinhua's economic development, while promoting local economic development, enable enterprises to grow better and faster.
Stick to Industry Unshakable, Five Aspects "Stick to" Re-innovate Performance
Over the years, Jianfeng Group has been sticking to Industry. This has also become an iron law for the development of the peak industry. 1993 7 March 28 , Jianfeng Group's shares were successfully listed on the Shanghai Stock Exchange, becoming the first listed company in the national cement industry. After years of exploration and integration of 20 , the peak finally formed a business pattern with cement and medicine as the main industry and health products, international trade and warehousing and logistics as the supplement.
Today's peak, from cement, medicine to warehousing, logistics, the system is more perfect. In the face of the achievements made in the past few years, Jiang Xiaomeng, chairman of Jianfeng Group, said that it was the land of Jinhua that nurtured the growth of Jianfeng, and striving to do a good job in the enterprise is the best return to Jinhua. He said, "Spike has been doing industry for more than 50 years and will not leave industry in the future".
Cement and medicine are all fully competitive industries. Why can an old company achieve such good new results? Jiang Xiaomeng believes that in addition to continuously strengthening the adjustment of its own industrial structure in accordance with the changes in the economic environment, the sound development of the peak in recent years has benefited from the persistence of five aspects: adhere to the development strategy of "cooperative innovation to strengthen the main business, standardize science and seek development"; adhere to accurate market positioning according to its own reality, that is, leading the cost of cement and being a niche in the regional market, leading pharmaceutical technology, leading enterprise in product market segmentation, natural raw materials in health product industry and leader in health product innovation; A control system of "strict budget effective authorization" has been established and implemented persistently. It has a management team that is united and pragmatic, pioneering and innovative, with reasonable age composition and solid and comprehensive knowledge structure. After several generations of peak people continuously refined and enriched, A corporate culture that meets the needs of peak reality and development has been formed.
Enterprise development of the effectiveness of the heavy, energy conservation and environmental protection at all costs to invest
as a leading enterprise at the level of Jinhua City, the sharp peak group will be for the "three corridors" construction of what "action"? Faced with this problem, Jiang Xiaomeng said, the peak in recent years has been doing industrial restructuring, in fact, and Jinhua "three corridors" overall construction framework fit.
In terms of ecological development, as early as ten years ago, Jianfeng had consciously transferred the high-pollution and high-emission cement industry to other places, using local resource advantages and market advantages to vigorously promote environmental protection and energy-saving transformation such as waste heat power generation, desulfurization, and denitration while making profits, and successfully realized the upgrading of traditional industries; based on Jinhua's Jianfeng pharmaceutical industry, the Jinxi production base with an investment of 5.8 .6 billion yuan has been fully put into operation in 2015 . From the beginning of the design, it has set high standards for energy conservation, emission reduction and comprehensive utilization of resources. Peak Health, a new enterprise, uses natural plants as raw materials to produce and sell healthy products. It has already made a lot of investment in the construction of ecological raw material bases, emission reduction and environmental protection.
Among them, in terms of environmental protection construction, Peak will continue to invest 3 million yuan in the next three years to carry out emission rectification.
In terms of transportation and logistics, the board of directors of Jianfeng Group held recently passed a resolution to invest 7 million yuan in jindong district to build a modern e-commerce park, which is beneficial and complementary to Jianfeng's original bonded storage, logistics, futures delivery and other businesses. In addition, the construction of traffic corridors is bound to have a large number of engineering construction, which will also bring new development opportunities to the cement building materials industry. The new strategy of
focuses on the future. Scientific and technological innovation promotes the transformation and upgrading of enterprises
. In terms of scientific and technological innovation, Jianfeng Pharmaceutical has established the research and development idea of "2 " with anti-infective drugs, cardiovascular and cerebrovascular drugs, drugs for elderly children and anti-tumor drugs as the main line, antidepressant drugs and eye drops as supplements, and timely entering the field of biological agents, extensive and in-depth cooperation with relevant universities and research institutes.
If Professor Wang Guangji, an academician of the Chinese Academy of Engineering, is hired as the chief scientist, the national first-class anti-tumor new drug being developed by his scientific research team has been included in the national major innovation plan this year; Sichuan Antibiotic Research Institute, which has been cooperating with Jianfeng for many years, is currently planning to establish a branch in Jinhua, further cooperation with Spike Pharmaceuticals in product, business and technical exchanges... These will lay a good foundation for Spike Pharmaceuticals to upgrade its products and expand its industry.
In addition to the above aspects, Jianfeng will invest more than 3 million yuan in the near future to upgrade the original drug production line to the US and EU standard GMP to create basic conditions for preparation products to go abroad. Guangxi Huibaoyuan Pharmaceutical Technology Company, which has recently participated in the reorganization, has introduced experts and technologies from Yale University in the United States to conduct innovative research and development and production; in Jinhua's pharmaceutical enterprises, only the planned investment in product research and development has reached 1.5 .8 billion yuan. Jiang Xiaomeng said that the provincial government and the municipal government recently issued support policies to reduce corporate taxes, which provided new assistance for enterprises to participate in the construction of the "three corridors. Jinhua's enterprises and entrepreneurs should seize this favorable opportunity to participate in the construction of the "three corridors" and contribute to Jinhua's economic and social development.
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page